Clinical Trial Update: Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients [Phase 2]

View source ↗

Summary

A Phase 2 prospective, randomized, double-blind, placebo-controlled, crossover trial in symptomatic celiac disease patients sponsored by Entero Therapeutics has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Entero Therapeutics investigational therapy

Snippet

Sponsor: Entero Therapeutics | Conditions: Celiac Disease | Phase 2 | Status: TERMINATED